首页> 外文会议>the European Peptide Symposium >MOLECULAR MECHANISM OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI'S) INTERACTIONS WITH SEROTONIN TRANSPORTER
【24h】

MOLECULAR MECHANISM OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI'S) INTERACTIONS WITH SEROTONIN TRANSPORTER

机译:选择性血清素再摄取抑制剂(SSRI)与血清素转运蛋白相互作用的分子机制

获取原文

摘要

Serotonin selective reuptake inhibitors (SSRIs) are currently among the most frequently prescribed therapeutic agents in depression. Their therapeutic use also includes obsessive-compulsive disorder, panic disorder and bulimia. The serotonin transporter (SERT), which consists of 12 transmembrane helices (TMH) with the amino and carboxy terminals localized intracellularly, is the molecular target of SSRIs. The understanding of the mechanism of action of SERT remains a primary goal in the search for developing novel treatments for diseases associated with serotonergic dysfunction.
机译:血清素选择性再摄取抑制剂(SSRIS)目前是抑郁症中最常规定的治疗剂中的最常规定的治疗剂。他们的治疗用途还包括强迫症,恐慌症和贪食症。血清素转运蛋白(SERT),由12个跨膜螺旋(TMH)组成,其中氨基和羧基末端局部化细胞内,是SSRIS的分子靶标。对SERT行动机制的理解仍然是寻求开发与血清onOronergic功能障碍相关的疾病的新疗法的主要目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号